MedTrace Logo

Collection of Performance Data From the Integrated Sensor and Infusion Set. TRIAL 4

NCT01775059 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2013-02-05

No results posted yet for this study

Summary

This is a multi-center, non-randomized, and interventional study in which subjects will use the Integrated sensor and infusion set with MiniLink Transmitter and the Medtronic Paradigm® VEO™ insulin pump (Sensor augmented pump) for 15 days.

The purpose of this study is to collect performance data on the Integrated sensor and infusion set for approximately 15 days, with the intention for each subject to wear 5 sets for 3 days each.

Conditions

  • Diabetes Mellitus Type I
  • Diabetes Mellitus Type II

Interventions

DEVICE

Integrated sensor and infusion set.

Sponsors & Collaborators

  • Medtronic Diabetes R&D Denmark

    lead INDUSTRY

Principal Investigators

  • Ulrik Pedersen-Bjergaard, MD · Hilleroed Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2013-07-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01775059 on ClinicalTrials.gov